Thomas Sciascia insider trades

Open-market stock purchases and sales by Thomas Sciascia, Chief Scientific Officer at Trevi Therapeutics, Inc, from SEC Form 4 filings since Mar 5, 2010.

Recent trades

DateStockTradeValue
Feb 19, 2026TRVI Trevi Therapeutics, IncBought (not open market)—

Companies traded

  • TRVI Trevi Therapeutics, Inc: 6 sales, last Feb 19, 2026
  • PPCO Penwest Pharmaceuticals Co: other filings, last Sep 20, 2010

Get free alerts when Thomas Sciascia files a new trade →